Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Lijun Zhou; X-D Liu; Mingli Sun; Xian Zhang; Polina German; Shanshan Bai; Zhiyong Ding; Nizar M. Tannir; Christopher G. Wood; Surena F. Matin; José A. Karam; Pheroze Tamboli; Kanishka Sircar; Priya Rao; Erinn B. Rankin; Douglas Laird; Anh Hoang; Cheryl L. Walker; Amato J. Giaccia; Eric Jonasch

doi:10.1038/onc.2015.343

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Lijun Zhou(The University of Texas MD Anderson Cancer Center), X-D Liu(The University of Texas MD Anderson Cancer Center), Mingli Sun(The University of Texas MD Anderson Cancer Center), Xian Zhang(The University of Texas MD Anderson Cancer Center), Polina German(The University of Texas MD Anderson Cancer Center), Shanshan Bai(The University of Texas MD Anderson Cancer Center), Zhiyong Ding(The University of Texas MD Anderson Cancer Center), Nizar M. Tannir(The University of Texas MD Anderson Cancer Center), Christopher G. Wood(The University of Texas MD Anderson Cancer Center), Surena F. Matin(The University of Texas MD Anderson Cancer Center), José A. Karam(The University of Texas MD Anderson Cancer Center), Pheroze Tamboli(The University of Texas MD Anderson Cancer Center), Kanishka Sircar(The University of Texas MD Anderson Cancer Center), Priya Rao(The University of Texas MD Anderson Cancer Center), Erinn B. Rankin(Stanford University), Douglas Laird(Exelixis (United States)), Anh Hoang(The University of Texas MD Anderson Cancer Center), Cheryl L. Walker(Texas A&M Health Science Center), Amato J. Giaccia(Stanford University), Eric Jonasch(The University of Texas MD Anderson Cancer Center)

Oncogene

September 14, 2015

10.1038/onc.2015.343

Cited by 391Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis